logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
09/03/2026
Hims will no longer advertise the lower-priced combination GLP-1 class medications.
Latest
2 m ago
The NASDAQ China Golden Dragon Index fell more than 0.5%, with iQiyi dropping 4.17%, Youxinche falling 4.29%, Hesai Technology down 4.13%, Jianan Technology down 4.01%, and Zhongbi Energy falling 3.47%.
2 m ago
Two members of the UAE armed forces have died in a helicopter accident.
3 m ago
NATO spokesperson reiterates that NATO is firmly prepared to defend all allies from any threat.
3 m ago
Market news: OpenClaw developer Peter Stenberg will be joining OpenAI company to help the ChatGPT developer enrich its product line.
3 m ago
Analyst: Hims & Hers itself will not profit from Novo Nordisk's GLP-1s drugs.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.